Bullboard - Stock Discussion Forum Grace Therapeutics, Inc GRCE

Healthcare

Grace Therapeutics, Inc., formerly Acasti Pharma Inc., is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its therapeutic pipeline consists of three clinical-stage drug candidates supported by an intellectual property portfolio of over 40 granted and pending patents in various jurisdictions. Its lead drug candidate, GTX-104, is a clinical-stage, novel... see more

Add To Watchlist

NDAQ:GRCE - Post Discussion

Grace Therapeutics, Inc > Why Today?

View:

Post by Danny1082Man on Aug 13, 2020 10:00am

Why Today?

They could have easily pushed out earnings PR into September. What is the motivation to tell they market they diluted with another 4 million shares with the ATM. Along with increased salaries verses conserving cash. It effectively diminishes a run up into data release. Almost like they are trying to bury this company and crush shareholders.

288

Comment

Comment by lscfa on Aug 13, 2020 10:10am

Nasdaq deadline to report Q2.......

166

Comment

Comment by Danny1082Man on Aug 13, 2020 12:48pm

August is not the deadline to report.

107

Comment

Comment by Francine01 on Aug 13, 2020 1:22pm

Dany, your are either, drunk, stupid or ignorant. As per Nasdaq rules, Acasti is required to filled their quarterly financial statements no later than 45 days after quarter ended of the June 30, 2020. 45 days is August 14th, they decided to filled the 13th. today, other than the quarter financial release, there was NOTHING new. ATM is used to give them at lease 9-12 months of cash ...more

201

Comment

Comment by Danny1082Man on Aug 13, 2020 2:29pm

You are correct. Mixed up my 10-K verses 10-Q filing dates. They are in time with everything, stock options, salary increases. Now just release the damn data and move on or put a fork in this

167

Comment

Grace Therapeutics, Inc